Document Classification

Section Type: RESULTS

Text: The total blood loss and HGB decrease were (1 198. 34 + / - 222. 06) mL and (33. 29 + / - 4. 99) g/L in the rivaroxaban group and were (1 124. 43 + / - 261. 01) mL and (31. 57 + / - 6. 17) g/L in the control group, showing no significant difference (P > 0. 05) ; the postoperative dominant blood loss in the rivaroxaban group [(456. 22 + / - 133. 12) mL] was significantly higher than that in the control group [(354. 53 + / - 96. 71) mL] (t = 4. 773, P = 0. 000).